The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson's disease
Carolin GabbertiD, Leonie Blöbaum, Theresa LüthiD, Inke Regina KönigiD, Amke CaliebeiD, Sebastian SendeliD, Björn‐Hergen LaabsiD, Christine KleiniD, Joanne TrinhiD
Abstract
ObjectiveTo investigate the association between a Parkinsons disease (PD)-specific polygenic score (PGS) and protective lifestyle factors on age at onset (AAO) in PD. MethodsWe included data from 4375 patients with idiopathic PD, 167 patients with GBA1-PD, and 3091 healthy controls of European ancestry from AMP-PD, PPMI, and Fox Insight cohorts. The PGS was calculated based on a previously proposed composition of 1805 variants. The association between PGS and lifestyle factors (i.e., coffee, tobacco, and aspirin) on AAO was assessed with linear and Cox proportional hazards models. ResultsThe PGS showed a negative association with AAO ({beta}=-1.07, p=6x10-7). The use of one, two, or three of the protective lifestyle factors showed a reduction in the hazard ratio by 21% (p=0.0001), 45% (p0.05). InterpretationIn our cohort, coffee, tobacco, aspirin, and PGS are independent predictors of PD AAO. Additionally, lifestyle factors seem to have a greater influence on AAO than common genetic risk variants with aspirin presenting the largest effect. External validation of our findings is needed.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 15
- FWCI
- 4.01
- Field percentile
- top 5%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Coffee, smoking and aspirin are associated with age at onset and clinical severity in idiopathic Parkinson's disease
Carolin Gabbert, Inke Regina König, … Joanne Trinh·Journal of NeurologyPeer-reviewed·Mar 2, 2022
- Genetic Modifiers of Age at Onset for Parkinson's Disease in European Populations
the Global Parkinson’s Genetic Program (GP2), Erin R. Voss·medRxiv·Oct 26, 2026
- Parkinsons disease determinants, prediction and gene-environment interactions in the UK Biobank
Benjamin M. Jacobs, Daniel Belete, … Alastair John Noyce·Journal of Neurology Neurosurgery & PsychiatryPeer-reviewed·Sep 15, 2020
- Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson's Disease Risk
Yingnan Han, Erin A. Teeple, … Dinesh Kumar·medRxiv·Oct 16, 2020
- Parkinson disease age of onset GWAS: defining heritability, genetic loci and a-synuclein mechanisms
Cornelis Blauwendraat, Karl Heilbron, … Andrew Singleton·Movement DisordersPeer-reviewed·Apr 7, 2019
- Interaction of mitochondrial polygenic score and environmental factors in LRRK2 p.Gly2019Ser parkinsonism
Theresa Lüth, Carolin Gabbert, … Joanne Trinh·medRxiv·Jan 2, 2023